PUBLISHER: QYResearch | PRODUCT CODE: 1073213
PUBLISHER: QYResearch | PRODUCT CODE: 1073213
Due to the COVID-19 pandemic, the global Iodine Contrast Media market size was value at US$ 3,564.19 million in 2021 and is forecast to be a readjusted size of US$ 4,926.37 million by 2028 with a CAGR of 4.39% during the forecast period 2022-2028.
The global main manufacturers of Iodine Contrast Media include GE Healthcare, Bracco Imaging, Bayer, Guerbet Group, Hengrui Medicine, YRPG and BeiLu Pharma, etc. In 2021, the global six largest players have a share approximately 95.26% in terms of revenue.
The North America Iodine Contrast Media market size was US$ 1,087.32 million in 2021, while China was about US$ 745.70 million. The proportion of the China was 20.92% in 2021 and it is predicted that the share will reach 27.79% in 2028, trailing a CAGR of 8.28% through the analysis period. As for the Europe Iodine Contrast Media landscape, Germany is projected to reach US$ 223.23 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 2.58% and 3.85% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, Iohexol accounting for 31.12% of the Iodine Contrast Media global market in 2021, is projected to value US$ 1,595.55 million by 2028, growing at a revised 5.11% CAGR from 2022 to 2028. While Hospitals segment is altered to an 6.41% CAGR throughout this forecast period and will hold a share about 32.39% in 2028.
The global Iodine Contrast Media market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Iodine Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.